Islay Capital Management’s Medifast MED Stock Holding History

Islay Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-597	Closed	-$102K	–	307
2022 Q1	$102K	Sell	597 -36	-6%	-$6.79K	0.08%	148
2021 Q4	$133K	Buy	+633	New	+$131K	0.1%	128
2021 Q2	–	Sell	-599	Closed	-$127K	–	300
2021 Q1	$127K	Buy	+599	New	+$143K	0.1%	133
2020 Q1	–	Sell	-718	Closed	-$79K	–	275
2019 Q4	$79K	Buy	+718	New	+$69.5K	0.08%	137

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NPIC

Neumeier Poma Investment Counsel Carmel, California $1.46B AUM 71.13% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Islay Capital Management's MED Position: Q2 2022 in Review

Islay Capital Management sold out of Medifast (MED) in Q2 2022, closing a stake of 597 shares — an estimated $102K sold.

Islay Capital Management first reported a position in MED in Q4 2019 and held it in 4 quarters. The position peaked at $133K in Q4 2021. 284 funds tracked by Wall St. Rank hold MED as of Q2 2022.

Islay Capital Management reported no remaining Medifast position as of Q2 2022 after selling out during the quarter.
Islay Capital Management sold 597 Medifast shares in Q2 2022, an estimated $102K.
Islay Capital Management first reported a position in Medifast in Q4 2019 and held it in 4 quarters.
Islay Capital Management's Medifast position peaked at $133K in Q4 2021.
284 funds tracked by Wall St. Rank held Medifast as of Q2 2022.

Based on Islay Capital Management's 13F filing for Q2 2022, filed 8 Aug 2022.